Hello all. I've written another article for Pharmacy Times. We've written about monoclonal antibodies previously (here, and here)..but this is a more "consolidated" and coherent article on the subject.

You can check it out here:

Clinical, Pharmacy School, Practice, ResidencyBrandon DysonAugust 31, 2016pharmacy times, monoclonal antibody guide, monoclonal antibodies made simple, monoclonal antibodies, monoclonal antibody clinical pearls, monoclonal antibody nomenclature, mabs, -mab

The Ultimate Guide to Oncology Pharmacy for the Non-Oncologist

Oncology pharmacy is hard.

Like, really hard.

You get a 3 - 5 week module during school. Maybe you have an APPE rotation. But there's just too much. Too many types of cancers. Too much history that explains how we got to where we are.

Clinical, Pharmacy School, Practice, ResidencyBrandon DysonJuly 31, 2016oncology, oncology pharmacy, cinv, ESA, G-CSF, GM-CSF, chemotherapy, Monoclonal Antibodies, -mab, tyrosine kinase inhibitor, TKI, neutropenic fever, febrile neutropenia, chemotherapy cheat sheet, hypercalcemia of malignancy, tumor lysis syndrome, colony stimulating factors, cytotoxic, chemo, cancer, oncology clinical pearls, chemotherapy clinical pearls, chemotherapy induced nausea and vomiting, cinv clinical pearls, cancer clinical pearls, erythropoietin stimulating agents, ESA APPRISE, platelet stimulating agents, infusion reaction, Anticoagulation, anticoagulation in cancer patients, tyrosine kinase inhibitor clinical pearls, monoclonal antibody clinical pearls, carboplatin, carboplatin dosing, the calvert formula, dose limiting toxicity, oncology cheat sheet, targeted therapy cheat sheet, chemo cheat sheet

New FDA Approval: Cinqair

Drug

Reslizumab [Cinqair]

Indication

It's yet another monoclonal antibody (YAMA? #YAMA?) approved for the treatment of severe asthma that is poorly controlled.